GBIO
GBIO
NASDAQ · Biotechnology

Generation Bio Co

$5.34
-0.40 (-6.97%)
As of Aug 22, 2:29 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +226.6% upside
Low Target $9.95
Average Target $17.44
High Target $18.08
Current Price $5.34
Current
$5.34
Target
$17.44
$9.95 $17.44 avg $18.08
Scenario Analysis
Bear Case
$9.95
86.3%
Low target
Base Case
$17.44
+226.6%
Avg target
Bull Case
$18.08
+238.6%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$6.92
-22.8% from high
52-Week Low
$4.91
+8.8% from low
Target vs 52W High
$17.44
+152.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%